文献速递癫痫

下托锥体神经元调控颞叶癫痫耐药性

Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy.
PubMed 文献 · Ann Neurol · 2019-08-12

该研究在苯妥英耐药癫痫模型中,结合电生理、光遗传学和化学遗传学方法,发现下托锥体神经元是苯妥英耐药的关键靶点。选择性抑制下托锥体神经元可逆转耐药,而激活则诱导耐药;长期低频刺激下托可抑制这些神经元并逆转耐药。

要点

  • 下托锥体神经元是颞叶癫痫苯妥英耐药的关键开关。
  • 抑制下托锥体神经元可逆转耐药,激活则诱导耐药。
  • 长期低频刺激下托是临床可行的逆转耐药策略。

核心结论

  • 下托锥体神经元可能是耐药性癫痫的关键控制开关,并代表精准治疗的新潜在靶点。

研究设计与样本

  • 研究在经典苯妥英耐药癫痫模型中采用电生理、光遗传学和化学遗传学等多方法。

主要发现

  • 在苯妥英耐药大鼠中,下托锥体神经元的放电率不能被苯妥英抑制,而其他海马亚区不受影响。
  • 光遗传学或化学遗传学选择性抑制下托锥体神经元可逆转苯妥英耐药,选择性激活则诱导耐药。
  • 长期低频刺激下托可显著抑制下托锥体神经元并逆转苯妥英耐药。
  • 体外电生理显示苯妥英对下托锥体神经元钠通道的脱靶使用参与耐药。
  • 临床神经影像数据提示耐药患者下托体积与钠通道抑制剂使用相关。

临床怎么用

  • 长期低频刺激下托可作为临床可行的逆转苯妥英耐药策略。
  • 下托锥体神经元可作为精准治疗耐药性癫痫的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Drug-resistant epilepsy causes great clinical danger and still lacks effective treatments. METHODS: Here, we used multifaceted approaches combining electrophysiology, optogenetics, and chemogenetics in a classic phenytoin-resistant epilepsy model to reveal the key target of subicular pyramidal neurons in phenytoin resistance. RESULTS: In vivo neural recording showed that the firing rate of pyramidal neurons in the subiculum, but not other hippocampal subregions, could not be inhibited by phenytoin in phenytoin-resistant rats. Selective inhibition of subicular pyramidal neurons by optogenetics or chemogenetics reversed phenytoin resistance, whereas selective activation of subicular pyramidal neurons induced phenytoin resistance. Moreover, long-term low-frequency stimulation at the subiculum, which is clinically feasible, significantly inhibited the subicular pyramidal neurons and reversed phenytoin resistance. Furthermore, in vitro electrophysiology revealed that off-target use of phenytoin on sodium channels of subicular pyramidal neurons was involved in the phenytoin resistance, and clinical neuroimaging data suggested the volume of the subiculum in drug-resistant patients was related to the usage of sodium channel inhibitors. INTERPRETATION: These results highlight that the subicular pyramidal neurons may be a key switch control of drug-resistant epilepsy and represent a new potential target for precise treatments. ANN NEUROL 2019;86:626-640.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Xu C, Wang Y, Zhang S, et al. Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy. Ann Neurol. 2019. PMID: 31340057. doi:10.1002/ana.25554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。